The utility of biomarkers in hepatocellular carcinoma: review of urine-based (1)H-NMR studies – what the clinician needs to know

Hepatocellular carcinoma (HCC) is the fifth most common malignancy, the third most common cause of cancer death, and the most common primary liver cancer. Overall, there is a need for more reliable biomarkers for HCC, as those currently available lack sensitivity and specificity. For example, the cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cartlidge, Caroline R, U, M R Abellona, Alkhatib, Alzhraa M A, Taylor-Robinson, Simon D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708191/
https://www.ncbi.nlm.nih.gov/pubmed/29225478
http://dx.doi.org/10.2147/IJGM.S150312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708191/
https://www.ncbi.nlm.nih.gov/pubmed/29225478
http://dx.doi.org/10.2147/IJGM.S150312

Ejemplares similares